Kineta Announces Participation in the H.C. Wainwright 24th Annual Global Healthcare Conference

/PRNewswire/ -- Kineta, Inc. ("Kineta" or the "Company"), a clinical-stage biotechnology company focused on the development of novel immunotherapies in...

Related Keywords

New York ,United States ,Shawn Iadonato ,Exchange Commission ,Linkedin ,Yumanity Therapeutics Inc ,Prnewswire Kineta Inc ,Facebook ,Lotte New York Palace Hotel ,Annual Global Investment ,Chief Executive Officer ,Annual Global Investment Conference ,Hybrid Conference ,Yumanity Therapeutics ,Registration Statement ,Investor Relations ,Securities Act ,Definitive Proxy Statement ,Kineta ,Nc ,